—
We haven't found any bio for you yet.
Loading links...
Loading publications…
Jordi Bruix, Ann‐Lii Cheng, Gerold Meinhardt, Keiko Nakajima, Yoriko De Sanctis, Josep M. Llovet (2017). Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies. Journal of Hepatology, 67(5), pp. 999-1008, DOI: 10.1016/j.jhep.2017.06.026.